Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 328

1.

Synthesis of Dihydropyrano[3,2-c]pyrazoles via Double Bond Migration and Ring-Closing Metathesis.

Usami Y, Sumimoto K, Kishima A, Tatsui Y, Yoneyama H, Harusawa S.

Molecules. 2019 Jan 15;24(2). pii: E296. doi: 10.3390/molecules24020296.

2.

Synthesis and structure-activity relationships of tetrazolato-bridged dinuclear platinum(II) complexes: A small modification at tetrazole C5 markedly influences the in vivo antitumor efficacy.

Komeda S, Yoneyama H, Uemura M, Tsuchiya T, Hoshiyama M, Sakazaki T, Hiramoto K, Harusawa S.

J Inorg Biochem. 2019 Mar;192:82-86. doi: 10.1016/j.jinorgbio.2018.12.009. Epub 2018 Dec 23.

PMID:
30612029
3.

[Global Trends Survey for Targeted Radionuclide Therapy].

Hanaoka K, Maeda T, Miyaji N, Sakaguchi K, Yoneyama H, Ogawa M, Tsushima H.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2018 Dec;74(12):1443-1448. doi: 10.6009/jjrt.2018_JSRT_74.12.1443. Japanese.

4.

A strong structural correlation between short inverted repeat sequences and the polyadenylation signal in yeast and nucleosome exclusion by these inverted repeats.

Miura O, Ogake T, Yoneyama H, Kikuchi Y, Ohyama T.

Curr Genet. 2018 Nov 29. doi: 10.1007/s00294-018-0907-8. [Epub ahead of print]

PMID:
30498953
5.

Clinical efficacy of free androgen index, a surrogate hallmark of circulating free testosterone level, in male patients with HCV-related chronic liver disease.

Himoto T, Fujita K, Sakamoto T, Nomura T, Morishita A, Yoneyama H, Haba R, Masaki T.

J Clin Biochem Nutr. 2018 Nov;63(3):238-245. doi: 10.3164/jcbn.18-30. Epub 2018 Jun 8.

6.

Characteristics of iodine-123 IQ-SPECT/CT imaging compared with conventional SPECT/CT.

Shibutani T, Onoguchi M, Yoneyama H, Konishi T, Matsuo S, Nakajima K.

Ann Nucl Med. 2019 Feb;33(2):103-111. doi: 10.1007/s12149-018-1310-8. Epub 2018 Oct 15.

PMID:
30324427
7.

Accuracy of an artificial neural network for detecting a regional abnormality in myocardial perfusion SPECT.

Shibutani T, Nakajima K, Wakabayashi H, Mori H, Matsuo S, Yoneyama H, Konishi T, Okuda K, Onoguchi M, Kinuya S.

Ann Nucl Med. 2019 Feb;33(2):86-92. doi: 10.1007/s12149-018-1306-4. Epub 2018 Oct 9.

PMID:
30302633
8.

Fibrosis Staging Using Direct Serum Biomarkers is Influenced by Hepatitis Activity Grading in Hepatitis C Virus Infection.

Fujita K, Kuroda N, Morishita A, Oura K, Tadokoro T, Nomura T, Yoneyama H, Arai T, Himoto T, Watanabe S, Masaki T.

J Clin Med. 2018 Sep 11;7(9). pii: E267. doi: 10.3390/jcm7090267.

9.

Circulating microRNA-636 is associated with the elimination of hepatitis C virus by ombitasvir/paritaprevir/ritonavir.

Morishita A, Yoneyama H, Iwama H, Fujita K, Watanabe M, Hirose K, Tadokoro T, Oura K, Sakamoto T, Mimura S, Nomura T, Oryu M, Himoto T, Shimotohno K, Masaki T.

Oncotarget. 2018 Aug 10;9(62):32054-32062. doi: 10.18632/oncotarget.25889. eCollection 2018 Aug 10.

10.

Grazoprevir/elbasvir treatment for the relapse of HCV genotype 1b infection after ledipasvir/sofosbuvir: A case report.

Tadokoro T, Morishita A, Oura K, Fujita K, Mimura S, Sakamoto T, Nomura T, Tani J, Yoneyama H, Masaki T.

Exp Ther Med. 2018 Aug;16(2):1026-1028. doi: 10.3892/etm.2018.6207. Epub 2018 May 23.

11.

Serum miRNAs Predicting Sustained HBs Antigen Reduction 48 Weeks after Pegylated Interferon Therapy in HBe Antigen-Negative Patients.

Fujita K, Mimura S, Iwama H, Nakahara M, Oura K, Tadokoro T, Nomura T, Tani J, Yoneyama H, Morishita A, Oryu M, Himoto T, Nishitsuji H, Shimotohno K, Omata M, Masaki T.

Int J Mol Sci. 2018 Jul 2;19(7). pii: E1940. doi: 10.3390/ijms19071940.

12.

Real-world virological efficacy and safety of elbasvir and grazoprevir in patients with chronic hepatitis C virus genotype 1 infection in Japan.

Toyoda H, Atsukawa M, Takaguchi K, Senoh T, Michitaka K, Hiraoka A, Fujioka S, Kondo C, Okubo T, Uojima H, Tada T, Yoneyama H, Watanabe T, Asano T, Ishikawa T, Tamai H, Abe H, Kato K, Tsuji K, Ogawa C, Shimada N, Iio E, Deguchi A, Itobayashi E, Mikami S, Moriya A, Okubo H, Tani J, Tsubota A, Tanaka Y, Masaki T, Iwakiri K, Kumada T.

J Gastroenterol. 2018 May 8. doi: 10.1007/s00535-018-1473-z. [Epub ahead of print]

PMID:
29740665
13.

Synthesis of Dihydrooxepino[3,2-c]Pyrazoles via Claisen Rearrangement and Ring-Closing Metathesis from 4-Allyloxy-1H-pyrazoles.

Usami Y, Kohno A, Yoneyama H, Harusawa S.

Molecules. 2018 Mar 6;23(3). pii: E592. doi: 10.3390/molecules23030592.

14.

Identification of a novel mechanism of action of bovine IgG antibodies specific for Staphylococcus aureus.

Furukawa M, Yoneyama H, Hata E, Iwano H, Higuchi H, Ando T, Sato M, Hayashi T, Kiku Y, Nagasawa Y, Niimi K, Usami K, Ito K, Watanabe K, Nochi T, Aso H.

Vet Res. 2018 Feb 26;49(1):22. doi: 10.1186/s13567-018-0517-y.

15.

Targeted sequencing of cancer-associated genes in hepatocellular carcinoma using next-generation sequencing.

Morishita A, Iwama H, Fujihara S, Watanabe M, Fujita K, Tadokoro T, Ohura K, Chiyo T, Sakamoto T, Mimura S, Nomura T, Tani J, Yoneyama H, Okano K, Suzuki Y, Himoto T, Masaki T.

Oncol Lett. 2018 Jan;15(1):528-532. doi: 10.3892/ol.2017.7334. Epub 2017 Nov 2.

16.

Development of immune and microbial environments is independently regulated in the mammary gland.

Niimi K, Usami K, Fujita Y, Abe M, Furukawa M, Suyama Y, Sakai Y, Kamioka M, Shibata N, Park EJ, Sato S, Kiyono H, Yoneyama H, Kitazawa H, Watanabe K, Nochi T, Aso H.

Mucosal Immunol. 2018 May;11(3):643-653. doi: 10.1038/mi.2017.90. Epub 2017 Dec 20.

PMID:
29346344
17.

Severe Steroid-responsive Skin Disorders Related to Ledipasvir and Sofosbuvir for HCV.

Tadokoro T, Morishita A, Fujita K, Oura K, Sakamoto T, Nomura T, Tani J, Yoneyama H, Masaki T.

Intern Med. 2018 Apr 15;57(8):1101-1104. doi: 10.2169/internalmedicine.9744-17. Epub 2017 Dec 27.

18.

Hand-Foot Syndrome and Post-Progression Treatment Are the Good Predictors of Better Survival in Advanced Hepatocellular Carcinoma Treated with Sorafenib: A Multicenter Study.

Ogawa C, Morita M, Omura A, Noda T, Kubo A, Matsunaka T, Tamaki H, Shibatoge M, Tsutsui A, Senoh T, Nagano T, Takaguchi K, Tani J, Morishita A, Yoneyama H, Masaki T, Moriya A, Ando M, Deguchi A, Kokudo Y, Minami Y, Ueshima K, Sakurai T, Nishida N, Kudo M.

Oncology. 2017;93 Suppl 1:113-119. doi: 10.1159/000481241. Epub 2017 Dec 20.

19.

Telmisartan inhibits hepatocellular carcinoma cell proliferation in vitro by inducing cell cycle arrest.

Oura K, Tadokoro T, Fujihara S, Morishita A, Chiyo T, Samukawa E, Yamana Y, Fujita K, Sakamoto T, Nomura T, Yoneyama H, Kobara H, Mori H, Iwama H, Okano K, Suzuki Y, Masaki T.

Oncol Rep. 2017 Nov;38(5):2825-2835. doi: 10.3892/or.2017.5977. Epub 2017 Sep 20.

20.

Induction of apoptosis by Galectin-9 in liver metastatic cancer cells: In vitro study.

Tadokoro T, Fujihara S, Chiyo T, Oura K, Samukawa E, Yamana Y, Fujita K, Mimura S, Sakamoto T, Nomura T, Tani J, Yoneyama H, Morishita A, Himoto T, Iwama H, Niki T, Hirashima M, Masaki T.

Int J Oncol. 2017 Aug;51(2):607-614. doi: 10.3892/ijo.2017.4053. Epub 2017 Jun 23.

PMID:
28656219

Supplemental Content

Loading ...
Support Center